Renal Cancer - Results from #2640

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial. July 23, 2020

Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience. July 22, 2020

Molecular Protein and Expression Profile in the Primary Tumors of Clear Cell Renal Carcinoma and Metastases. July 22, 2020

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma. July 21, 2020

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis. July 21, 2020

Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function - Curiosity or Relevant Issue? July 20, 2020

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial. July 20, 2020

Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression. July 17, 2020

Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. July 17, 2020

Comprehensive analysis of copy number variance and sensitivity to common targeted therapy in clear cell renal cell carcinoma: In silico analysis with in vitro validation. July 17, 2020

Transition from open partial nephrectomy directly to robotic surgery: experience of a single surgeon to achieve "TRIFECTA". July 16, 2020

Fatal fulminant hepatitis induced by combined ipilimumab and nivolumab therapy despite favorable histologic response and confirmed by autopsy in a patient with clear cell renal cell carcinoma. July 16, 2020

Nephron-Sparing Surgery for Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical T1 Stage: A Multicenter Study in China. July 16, 2020

The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial. July 15, 2020

Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study. July 15, 2020

Detection Of Tetraploidization In Chromophobe Renal Cell Carcinoma: Insights And Pitfalls. July 15, 2020

Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma. July 15, 2020

ImmunoPET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition. July 15, 2020

Serum long non-coding RNA LINC00887 as a potential biomarker for diagnosis of renal cell carcinoma. July 14, 2020

Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study. July 14, 2020

Page 133 of 456